PATENT CLAIM ANALYSIS

Application Number: 15744712
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "016800"]

Abstract:
Provided are fusion polypeptides comprising fragments from a first and a second FGF family member, nucleic acids encoding the fusion polypeptides, vectors and host cells containing the same, and methods of making and using such compositions in the treatment of FGF-related diseases, disorders, and conditions.

Claim (Index 7):
The fusion polypeptide of  claim 6 , wherein the fusion polypeptide has the ability to promote growth of BaF3 cells expressing said FGF receptor in vitro when applied at a concentration of less than about 100 ng/ml, 90 ng/ml, 80 ng/ml, 70 ng/ml, 60 ng/ml, 50 ng/ml, 40 ng/ml, 30 ng/ml, 29 ng/ml, 28 ng/ml, 27 ng/ml, 26 ng/ml, 25 ng/ml, 24 ng/ml, 23 ng/ml, 22 ng/ml, 21 ng/ml, 20 ng/ml, 19 ng/ml, 18 ng/ml, 17 ng/ml, 16 ng/ml, 15 ng/ml, 14 ng/ml, 13 ng/ml, 12 ng/ml, ling/ml, 10 ng/ml, 9 ng/ml, 8 ng/ml, 7 ng/ml, 6 ng/ml, 5 ng/ml, 4 ng/ml, 3 ng/ml, or 2 ng/ml.

Metadata:
- Claim Count in Document: 112.0
- Percentile: 86.0
- Lexical Diversity: 1.37838
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15107101', '14380277', '13515429', '15660116', '10251947']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7768353086090098
- 35 USC 102 Novelty (BERT): 0.5453475049926236
- Combined Prediction Score: 0.7536865282473713
- Mean Citation Score: 314.01251
- Max Citation Score: 411.7714
- Similarity Product: 257.29444093158247

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test